|Bid||9.45 x 2200|
|Ask||9.70 x 1400|
|Day's Range||9.47 - 9.65|
|52 Week Range||8.90 - 19.43|
|Beta (5Y Monthly)||1.73|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 02, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||20.67|
BRISBANE, Calif., August 31, 2021--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in fireside chats at the following investor conferences:
We can readily understand why investors are attracted to unprofitable companies. For example, although...
BRISBANE, Calif., August 09, 2021--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will participate in a fireside chat at the 2021 Wedbush PacGrow Healthcare Conference on Wednesday, August 11th at 2:55pm Eastern Time.